This week's episode of Heads UP is on the Estrogen and Migraine Controversy. Lindsay Weitzel, Ph.D. questions Susan Hutchinson, MD, Headache Specialist and author of The Woman's Guide to Managing Migraine all about estrogen, migraine, aura, stroke risk, birth control, perimenopause, HRT, bioidenticals, etc.
Dr. Hutchinson recently spoke to VJ Neurology re: many aspects of migraine suffering and recent developments in treatment. View the videos here: http://www.vjneurology.com/speaker/Susan-Hutchinson You can follow VJ Neurology on Twitter @VJNeurology
In this video from the AAN Annual Virtual Meeting 2021, Dr. Susan Hutchinson talks about her recent study evaluating the safety and tolerability of rimegepant in adults with CV risk factors, for the prevention and treatment of migraine. Click here to watch.
Check out Dr. Hutchinson’s recent interview on Good Day LA talking about migraine. Click here: https://www.foxla.com/video/919404
Dr. Susan Hutchinson is a featured speaker for next Saturday's (7/11/2020) Miles for Migraine Educational Event San Diego 2020. It is virtual and registration is free. Read on for more info.
As many of you are aware, I was asked to go to India with a team of international headache experts to educate local providers. Each one of us on the team had a specific purpose and for me, it was to focus on the treatment of migraine in women. The need for good migraine management in India is great. With a population of over 1.3 billion, the estimated prevalence of migraine in India is over 150,000 million. By comparison, the prevalence of migraine in the United States is 38 million.
A newly formed non-profit healthcare organization in India has asked a small team of US physicians to lead the way in educating Primary Care Physicians and neurologists about migraine. Dr. Hutchinson's focus will be the importance of treating migraine in women including the right for women to access medical care in the face of local [...]
Dr. Susan Hutchinson joined Dr. Jack Schim for a live Webcast on Thursday evening, October 25th, to discuss Ajovy, the second CGRP monoclonal Antibody approved for migraine prevention. It is an injection and offers the option of quarterly or monthly dosing.
Dr. Hutchinson 2nd Author On An Abstract Titled “Patterns and Characterization of Acute Prescription Headache Medication Use: Results from the CaMEO study”
Dr. Hutchinson was 2nd author on an abstract titled "Patterns and Characterization of Acute Prescription Headache Medication Use: Results from the CaMEO study" that was accepted as a poster presentation both at the recent American Headache Society Scientific Symposium in June 2018 and at the Diamond Headache Clinic Research & Educational Foundation in July 2018.
Reader’s Digest Online has included MigraineX and Dr. Hutchinson in an article titled, “The Sneaky Warning Signs a Migraine Is Coming—and How to Stop Them.”